Eric Trawick, MD
Gastroenterology · Lafayette, LANPI 1699979187
Payments from drug & device makers
Across 496 payments — averaging $420.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$156K
- Olympus Corporation Of The Americas$22K
- Reshape Lifesciences Inc.$16K
- Olympus America Inc.$7K
- Olympus Corporation$3K
- AbbVie$3K
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer(2 entities) | 73 | $155,589 |
| Olympus Corporation Of The Americas | 36 | $21,535 |
| Reshape Lifesciences Inc. | 2 | $15,917 |
| Olympus America Inc. | 11 | $6,750 |
| Olympus Corporation | 6 | $3,219 |
| AbbVie(2 entities) | 198 | $2,735 |
| Johnson & Johnson | 57 | $625 |
| Bristol Myers Squibb | 35 | $532 |
| Gilead | 19 | $310 |
| Boston Scientific | 4 | $285 |
| Medtronic | 3 | $251 |
| Sanofi | 2 | $159 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $145 |
| Merck | 7 | $116 |
| Nestle Healthcare Nutrition Inc. | 5 | $68 |
| Ironwood Pharmaceuticals, Inc | 4 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $26 |
| Covidien LP | 1 | $21 |
| Conmed Corporation | 1 | $20 |
| Amgen | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Enterra Medical, Inc. | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| QOL Medical, LLC | 1 | $12 |
| Concordia Pharmaceuticals Inc. | 1 | $12 |
| Braintree Laboratories, Inc. | 1 | $12 |
How this compares
$208,770 in reported general payments places this provider in the 90th percentile of 254 gastroenterology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Lafayette
- Jacob BreauxLafayette$407K
- Jacob KarrLafayette$182K
- Jacque NoelLafayette$88K
- Stephen AbshireLafayette$53K
- Erick SalvatierraLafayette$27K
- Humberto AguilarShreveport$13.1M
- Gary ReissMarrero$10M
- Bal BhandariBastrop$6.4M
- Gregory GaspardBaton Rouge$4M
- Jonathon ChapmanBaton Rouge$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.